# A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

> **NCT03200704** · PHASE3 · COMPLETED · sponsor: **Novadaq Technologies ULC, now a part of Stryker** · enrollment: 152 (actual)

## Conditions studied

- Breast Cancer
- Lymph Node Mapping
- Sentinel Lymph Node Biopsy

## Interventions

- **COMBINATION_PRODUCT:** IC2000 and SPY-PHI
- **COMBINATION_PRODUCT:** Tc-99m radioactive colloid and Gamma Probe

## Key facts

- **NCT ID:** NCT03200704
- **Lead sponsor:** Novadaq Technologies ULC, now a part of Stryker
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-04
- **Primary completion:** 2020-08-27
- **Final completion:** 2020-09-28
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03200704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03200704, "A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03200704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*